1. Academic Validation
  2. The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility

The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility

  • Cell. 2002 Oct 18;111(2):209-18. doi: 10.1016/s0092-8674(02)01012-7.
Yichin Liu 1 Lara Fallon Hilal A Lashuel Zhihua Liu Peter T Lansbury Jr
Affiliations

Affiliation

  • 1 Center for Neurologic Diseases, Brigham and Women's Hospital, Department of Neurology, Harvard Medical School, Cambridge, MA 02139, USA.
Abstract

The assumption that each Enzyme expresses a single enzymatic activity in vivo is challenged by the linkage of the neuronal Enzyme ubiquitin C-terminal hydrolase-L1 (UCH-L1) to Parkinson's disease (PD). UCH-L1, especially those variants linked to higher susceptibility to PD, causes the accumulation of alpha-synuclein in cultured cells, an effect that cannot be explained by its recognized hydrolase activity. UCH-L1 is shown here to exhibit a second, dimerization-dependent, ubiquityl Ligase activity. A polymorphic variant of UCH-L1 that is associated with decreased PD risk (S18Y) has reduced Ligase activity but comparable hydrolase activity as the wild-type Enzyme. Thus, the Ligase activity as well as the hydrolase activity of UCH-L1 may play a role in proteasomal protein degradation, a critical process for neuronal health.

Figures